Medical Device Contract Manufacturing Market Overview
The Medical Device Contract Manufacturing Market is expanding as medical device companies increasingly outsource design, manufacturing, assembly, packaging, and other production activities to specialized partners. Rising demand for complex medical devices, pressure to reduce manufacturing costs, shorter product development cycles, and the need for scalable production capacity are encouraging original equipment manufacturers to rely on contract manufacturing expertise.
According to the Market Research Future report updated August 24, 2026, the global Medical Device Contract Manufacturing Market was valued at USD 97.2 billion in 2025 and is projected to grow from USD 107.5 billion in 2026 to USD 221.4 billion by 2035, registering a CAGR of 10.6% during the forecast period 2026–2035. North America holds the largest regional share at approximately 40% of the global market, while Asia-Pacific is projected to be the fastest-growing region at a CAGR of around 12.2%. Component manufacturing represents the largest service category, while Device Development Services are among the fastest-growing areas. Class II medical devices account for the largest regulatory classification segment, while Class III devices are expected to register strong growth because of increasing demand for sophisticated implantable and life-supporting technologies.
Unlock Exclusive Insights – Request Your Free Sample Report Now!
Key players driving innovation and competitiveness in the Medical Device Contract Manufacturing Market include:
Jabil Inc.
Integer Holdings Corporation
Sanmina Corporation
Celestica Inc.
Flex Ltd.
TE Connectivity
Plexus Corp.
Benchmark Electronics
Creganna Medical
Nordson Corporation
The Medical Device Contract Manufacturing Market is being transformed by increasing product complexity, regulatory requirements, and manufacturers’ focus on asset-light operating models. Contract manufacturers are investing in advanced automation, precision machining, cleanroom manufacturing, additive manufacturing, and sophisticated testing capabilities to support increasingly complex devices. The integration of digital manufacturing, real-time quality monitoring, and supply-chain visibility is further helping contract manufacturers meet stringent medical-device quality requirements while improving production efficiency and traceability.
The Medical Device Contract Manufacturing Market can be segmented by Service Type, Device Type, Class of Device, and Region. By service type, the market includes Device Development Services, Component Manufacturing, Device Assembly, and Packaging & Sterilization, with Component Manufacturing representing the largest category and Device Development Services among the fastest-growing areas. By device type, the market covers Class I, Class II, and Class III medical devices, with Class II devices holding the largest share because of their broad application across diagnostic and therapeutic equipment. Class III devices are expected to witness significant growth due to increasing demand for sophisticated and highly regulated medical technologies. Regional markets include North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
Significant opportunities are emerging through nearshoring, dual-source manufacturing strategies, advanced automation, digital quality management, additive manufacturing, and integrated design-to-production services. Medical device companies are increasingly seeking partners that can support the complete product lifecycle, from engineering and prototyping to validation, regulatory compliance, manufacturing, packaging, and sterilization. Emerging manufacturing hubs in Asia-Pacific and other cost-competitive regions are also creating opportunities for international contract manufacturers to expand capacity while maintaining competitive production economics.
Recent Developments and Market Trends:
Medical device manufacturers are increasingly outsourcing complex production activities to specialized contract manufacturers to reduce capital expenditure and accelerate product commercialization.
Automation, robotics, and digital manufacturing technologies are being adopted across medical-device production facilities to improve precision, throughput, quality, and manufacturing consistency.
Nearshoring and regionalized supply chains are gaining importance as medical device companies seek greater resilience and reduced exposure to global logistics disruptions.
Additive manufacturing is creating new opportunities for rapid prototyping, patient-specific components, complex geometries, and low-volume production of specialized medical devices.
Integrated design-to-manufacturing services are gaining traction as OEMs increasingly prefer contract partners capable of supporting engineering, validation, regulatory compliance, assembly, packaging, and sterilization within a unified workflow.
Reasons to Buy the Report:
Understand the projected growth trajectory of the Medical Device Contract Manufacturing Market through 2035, including its 10.6% CAGR and forecast valuation of USD 221.4 billion.
Assess the competitive landscape and strategic positioning of leading contract manufacturers serving medical-device OEMs worldwide.
Identify the largest and fastest-growing service, device-class, and regional segments shaping future contract manufacturing opportunities.
Evaluate key market drivers, restraints, regulatory requirements, technological developments, and supply-chain trends influencing outsourcing decisions.
Gain strategic insights into automation, additive manufacturing, nearshoring, integrated production services, digital quality management, and emerging manufacturing hubs.
Future Outlook:
The Medical Device Contract Manufacturing Market is expected to experience strong growth through 2035 as medical-device OEMs increasingly prioritize specialized manufacturing capabilities, flexible capacity, cost optimization, and faster commercialization. Component Manufacturing is expected to remain the largest service category because of the extensive outsourcing of precision components and subassemblies, while Device Development Services are positioned for rapid growth as OEMs increasingly rely on external engineering expertise from early design through commercialization. Class II medical devices will continue to represent the largest device-class segment because of their broad use across diagnostics, monitoring, and therapeutic applications, while Class III devices are expected to experience significant growth as demand for complex implantable and life-supporting technologies rises. North America is expected to retain its leadership because of its mature medical-device ecosystem, advanced manufacturing infrastructure, and concentration of major OEMs, while Asia-Pacific is projected to remain the fastest-growing region at approximately a 12.2% CAGR due to expanding manufacturing capacity, skilled labor availability, and cost advantages. Overall, increasing outsourcing penetration, manufacturing automation, nearshoring, additive manufacturing, digital quality systems, and demand for integrated design-to-production services are expected to propel the Medical Device Contract Manufacturing Market to USD 221.4 billion by 2035.
➤➤Explore Our Latest Related Reports:
